Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (151-160 of 308) with videos related to

Pageof 31
Sort By:
Annals of Internal Medicine|November 16, 2011
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trialSam Schulman, Sameer Parpia, Clare Stewart, et al.
Journal of Thrombosis and Haemostasis : JTH|July 4, 2020
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of AnticoagulationMarcello Di Nisio, Emanuele Valeriani, Nicoletta Riva, et al.
Pharmacotherapy|June 8, 2013
Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysisJason Lam, Sam Schulman, Daniel M Witt, et al.
Journal of Clinical Pharmacology|January 25, 2007
NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I studyDag Nilsson, Johan Wemer, Yi-Fang Cheng, et al.
Thrombosis Research|November 15, 2017
Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysisChatree Chai-Adisaksopha, Alfonso Iorio, Christopher Hillis, et al.
Blood Transfusion = Trasfusione Del Sangue|June 6, 2013
Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trialsPier Mannuccio Mannucci, Paul Alexander Kyrle, Sam Schulman, et al.
Obstetrics and Gynecology|August 28, 2014
Association of venous thromboembolism with hormonal contraception and thrombophilic genotypesAnnica Bergendal, Ingemar Persson, Jacob Odeberg, et al.
American Heart Journal|December 12, 2017
Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trialNathan P Clark, James D Douketis, Vic Hasselblad, et al.
Thrombosis and Haemostasis|October 25, 2013
Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrateAmmar Majeed, Karina Meijer, Ramiro Larrazabal, et al.
Thrombosis and Haemostasis|December 1, 2021
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative ReviewIlia Makedonov, Susan R Kahn, Jameel Abdulrehman, et al.
Pageof 31

Showing results (151-160 of 308) with videos related to

Sort By:
Pageof 31
Annals of Internal Medicine|November 16, 2011
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trialSam Schulman, Sameer Parpia, Clare Stewart, et al.
Journal of Thrombosis and Haemostasis : JTH|July 4, 2020
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of AnticoagulationMarcello Di Nisio, Emanuele Valeriani, Nicoletta Riva, et al.
Pharmacotherapy|June 8, 2013
Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysisJason Lam, Sam Schulman, Daniel M Witt, et al.
Journal of Clinical Pharmacology|January 25, 2007
NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I studyDag Nilsson, Johan Wemer, Yi-Fang Cheng, et al.
Thrombosis Research|November 15, 2017
Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysisChatree Chai-Adisaksopha, Alfonso Iorio, Christopher Hillis, et al.
Blood Transfusion = Trasfusione Del Sangue|June 6, 2013
Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trialsPier Mannuccio Mannucci, Paul Alexander Kyrle, Sam Schulman, et al.
Obstetrics and Gynecology|August 28, 2014
Association of venous thromboembolism with hormonal contraception and thrombophilic genotypesAnnica Bergendal, Ingemar Persson, Jacob Odeberg, et al.
American Heart Journal|December 12, 2017
Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trialNathan P Clark, James D Douketis, Vic Hasselblad, et al.
Thrombosis and Haemostasis|October 25, 2013
Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrateAmmar Majeed, Karina Meijer, Ramiro Larrazabal, et al.
Thrombosis and Haemostasis|December 1, 2021
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative ReviewIlia Makedonov, Susan R Kahn, Jameel Abdulrehman, et al.
Pageof 31